Drug Chatter -- Tracking biopharma stock chatter

💊 Get Accurate, Objective, and Timely Intelligence From DrugPatentWatch

Profile for Biogen Inc. (BIIB)

« Back to company index

BIIB Chatter Timeline

Stock Ticker for BIIB

Most Active Tweeters for BIIB

UserTweets
@TradingSin21 18
@nekeji2097 11
@newsfilterio 8
@bthefirsttoknow 7
@FlashAlert_me 7

Recent Tweets for BIIB

PeterHa18329727 @PeterHa18329727
$BIIB *ALL THESE LEVELS POSTED AHEAD OF TIME BEFORE THE MARKET OPENED ??? https://t.co/v9tCYcZ0nW
4:01am
WhortonKathleen @WhortonKathleen
$BIIB "ALL THESE LEVELS POSTED AHEAD OF TIME BEFORE THE MARKET OPENED.??..?~~ https://t.co/Z2GnoT8lsq
2:01am
FlashAlert_me @FlashAlert_me
$BIIB [15s. delayed] filed SEC form 4: Insider ALEXANDER SUSAN H: Granted 5,703 of Common Stock at price $0 on 202… https://t.co/q3VC2TWyNa
2:01am
FlashAlert_me @FlashAlert_me
$BIIB [15s. delayed] filed SEC form 5: Insider Posner Brian S: Gifted 150 of Common Stock at price $0 on 2022-06-0… https://t.co/ASlCAAYrKT
2:01am
FlashAlert_me @FlashAlert_me
$BIIB [15s. delayed] filed SEC form 4: Insider Kramer Robin: Granted 887 of Common Stock at price $0 on 2023-01-25… https://t.co/CqVKqpkVTO
2:01am
FlashAlert_me @FlashAlert_me
$BIIB [15s. delayed] filed SEC form 4: Insider Singhal Priya: Granted 1,123 of Common Stock at price $0 on 2023-01… https://t.co/tz3Bizz6EZ
1:01am
FlashAlert_me @FlashAlert_me
$BIIB [15s. delayed] filed SEC form 4: Insider Murphy Nicole: Granted 1,340 of Common Stock at price $0 on 2023-01… https://t.co/Hv5DW88nGd
1:01am
FlashAlert_me @FlashAlert_me
$BIIB [15s. delayed] filed SEC form 5: Insider SHERWIN STEPHEN A: Gifted 695 of Common Stock at price $0 on 2022-1… https://t.co/bojRwnAejt
1:01am
FlashAlert_me @FlashAlert_me
$BIIB [15s. delayed] filed SEC form 4: Insider Gregory Ginger: Granted 4,452 of Common Stock at price $0 on 2023-0… https://t.co/CPDErdodOK
1:01am
BBaccSoon @BBaccSoon
@tradezero charging almost five a night to short literally two shares of $BIIB even though their own software shows… https://t.co/DoY0skLHTt
12:01am
Bulgari24287297 @Bulgari24287297
$BIIB Top analyst price target for next week....~ ?https://t.co/xQRlbf04l2
12:01am
Slayer10Stock @Slayer10Stock
$BIIB Put-Call ratio by Volume => 0.49 @ 2023-01-27. Learn more at https://t.co/54bj3mKa5j. #BIIBSTOCK #Ticker https://t.co/ht3WHl8fVJ
January 27th 2023, 11:01pm
newsfilterio @newsfilterio
Form 5 (annual statement of changes in beneficial ownership of securities) filed with the SEC $BIIB https://t.co/1XC13dWyyg
January 27th 2023, 11:01pm
newsfilterio @newsfilterio
Form 5 (annual statement of changes in beneficial ownership of securities) filed with the SEC $BIIB https://t.co/c8QMcvrVfv
January 27th 2023, 11:01pm
TradingSin21 @TradingSin21
$BIIB Trading Ideas | Awaiting Short signal. 100% Profitability based on 3 trades. Profit factor is 100. Learn more… https://t.co/7pr8eoaQTY
January 27th 2023, 8:01pm
jbetlach @jbetlach
(Reuters) - Japanese drugmaker Eisai Co Ltd and Biogen Inc $BIIB said on Thursday the European Medicines Agency (EM… https://t.co/YWsLYP5Tuh
January 27th 2023, 4:01pm
TroyAda06584292 @TroyAda06584292
$BIIB *Top analyst target price for next week - https://t.co/JqhJc6wi6Q
January 27th 2023, 3:01pm
PopplewellTy @PopplewellTy
RT @ParagonIntelNYC: Today at 1pm ET we are hosting a call on our work on $BIIB CEO Viehbacher We are Positive on CEO Viehbacher strategic…
January 27th 2023, 1:01pm
prosan40618812 @prosan40618812
$BIIB "ALL THESE LEVELS POSTED AHEAD OF TIME BEFORE THE MARKET OPENED>?? https://t.co/lhVgPnAEZJ
January 27th 2023, 1:01pm
Any57746051 @Any57746051
$BIIB Top analyst price target for next week??>? ?https://t.co/KtniMl2W5C
January 27th 2023, 12:01pm
ConnorJBates_ @ConnorJBates_
$BIIB Potentially getting ready for a big move soon. 3 consecutive days of very tight price action and volume contr… https://t.co/lMYMcukdxO
January 27th 2023, 12:01pm
ParagonIntelNYC @ParagonIntelNYC
Today at 1pm ET we are hosting a call on our work on $BIIB CEO Viehbacher We are Positive on CEO Viehbacher strate… https://t.co/OhKaEeFyXX
January 27th 2023, 12:01pm
Gambiste1 @Gambiste1
RT @semodough: Goldberg - correct also as uptake of $BIIB Leqembi for Alzheimer’s Disease will likely ramp up in ‘24/’25” Bodes very Positi…
January 27th 2023, 4:01am
LauermanJohn @LauermanJohn
RT @ZacharyBrennan: Europe wants in on lecanemab (Aduhelm was rejected there) $biib https://t.co/r85hcivrTp
January 27th 2023, 4:01am
steintrades @steintrades
RT @MichaelWalstedt: $BIIB textbook @markminervini VCP setup here Super tight price action with the largest decline coming in at only -15%…
January 27th 2023, 3:01am
bthefirsttoknow @bthefirsttoknow
First out// $BIIB: European Medicines Agency Accepted Marketing Authorization Application For Lecanemab As Treatment For Early Alzheimer's
January 27th 2023, 12:01am
Ainvest_Wire @Ainvest_Wire
EU regulator accepts for review Alzheimer's treatment from Eisai-Biogen - Reuters $BIIB #Alzheimer's Disease… https://t.co/oMrWWPOCDQ
January 27th 2023, 12:01am
StckPro @StckPro
$BIIB NEW ARTICLE : Marketing Authorization Application for Lecanemab as Treatment for Early Alzheimer's Disease Ac… https://t.co/KwLCPmFhrj
January 26th 2023, 11:01pm
ZacharyBrennan @ZacharyBrennan
Europe wants in on lecanemab (Aduhelm was rejected there) $biib https://t.co/r85hcivrTp
January 26th 2023, 11:01pm
StckPro @StckPro
$BIIB NEW ARTICLE : Marketing Authorization Application for Lecanemab as Treatment for Early Alzheimer's Disease Ac… https://t.co/QXu4uPOsAt
January 26th 2023, 11:01pm
semodough @semodough
Goldberg - correct also as uptake of $BIIB Leqembi for Alzheimer’s Disease will likely ramp up in ‘24/’25” Bodes ve… https://t.co/ilGvZ0AMWi
January 26th 2023, 11:01pm
Beeken_health @Beeken_health
$BIIB - Marketing Authorization Application for Lecanemab as Treatment for Early Alzheimer's Disease Accepted by Eu… https://t.co/1YXj4jUV9S
January 26th 2023, 11:01pm
algobotnews @algobotnews
Eisai, Biogen: EMA accepts MAA for lecanemab for early Alzheimer's disease $BIIB $ESALY
January 26th 2023, 11:01pm
stonkmooncom @stonkmooncom
$BIIB 2023-01-26 18:30 ET MARKETING AUTHORIZATION APPLICATION FOR LECANEMAB AS TREATMENT FOR EARLY ALZHEIMER'S D… https://t.co/eRByQPBMah
January 26th 2023, 11:01pm
StockNewsBot2 @StockNewsBot2
$BIIB Marketing Authorization Application for Lecanemab as Treatment for Early Alzheimer’s Disease Accepted by Euro… https://t.co/CcN0VxfwGa
January 26th 2023, 11:01pm
stock_titan @stock_titan
$BIIB Marketing Authorization Application for Lecanemab as Treatment for Early Alzheimer’s Disease Accepted by Euro… https://t.co/JR3cSxooxU
January 26th 2023, 11:01pm
UsMarketNews @UsMarketNews
$BIIB news Marketing Authorization Application for Lecanemab as Treatment for Early Alzheimer's Disease Accepte… https://t.co/Zb54OET7Hr
January 26th 2023, 11:01pm
bthefirsttoknow @bthefirsttoknow
First out// $BIIB: Marketing Authorization Application for Lecanemab as Treatment for Early Alzheimer's Disease Acc… https://t.co/PMfEgQHIQC
January 26th 2023, 11:01pm
Slayer10Stock @Slayer10Stock
$BIIB Open Interest => 69% (Puts) - 31% (Calls) @ 2023-01-27. Learn more at https://t.co/54bj3mKa5j. #BIIBSTOCK… https://t.co/RmjZqcDtUA
January 26th 2023, 10:01pm
V1stocks @V1stocks
@MichaelWalstedt @markminervini I also looked closely at $BIIB I also carefully looked at BIIB, yesterday I bought a little?
January 26th 2023, 9:01pm
MichaelWalstedt @MichaelWalstedt
$BIIB textbook @markminervini VCP setup here Super tight price action with the largest decline coming in at only -… https://t.co/PL7oJg5xFo
January 26th 2023, 9:01pm
Trade_Variance @Trade_Variance
? LARGE CALL SWEEP ORDER ? STOCK: $BIIB STRIKE: 300 EXPIRY: 7/21/2023 PREMIUM: $269,000
January 26th 2023, 5:01pm
TLandstreet @TLandstreet
Amyloid plaque might just be a symptom. A majority of older people develop it yet few develop dimencia. $BIIB might… https://t.co/PxT3vtAnOX
January 26th 2023, 5:01pm
TLandstreet @TLandstreet
Want to know about amyloid plaque and why Biogen has to force approval of lecanemab? Listen to this: $BIIB https://t.co/MWxuCwuRoa
January 26th 2023, 5:01pm
LilaDea34313666 @LilaDea34313666
$BIIB Top analyst price target for next week- https://t.co/OPwNHr9bn7
January 26th 2023, 4:01pm
TLandstreet @TLandstreet
Skepticism of $BIIB alzheimer's drug is growing. #lecanemab #leqembi https://t.co/C9SPL1u6EE
January 26th 2023, 1:01pm
StckPro @StckPro
$BIIB NEW ARTICLE : Is Biogen Stock a Buy Now? https://t.co/GHKkwLxj4F Get all the latest $BIIB related news here :… https://t.co/oUE2VWPhEg
January 26th 2023, 12:01pm
newsfilterio @newsfilterio
Massachusetts Virus Outbreak Looks Like Italy’s Just Two Weeks Ago $VRTX $BIIB https://t.co/iti1IoGT7O
January 26th 2023, 9:01am
Slayer10Stock @Slayer10Stock
$BIIB Open Interest => 69% (Puts) - 31% (Calls) @ 2023-01-27. Learn more at https://t.co/54bj3mKa5j. #BIIBSTOCK… https://t.co/Fw8oxtNVNA
January 25th 2023, 11:01pm
salomons_ed @salomons_ed
$BIIB Top analyst price target for next week>>> ?https://t.co/7vzzfiLE5g
January 25th 2023, 7:01pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2023. All rights reserved.